Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome-Positive (Ph plus ) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study

被引：0

作者：

Mauro, Michael J. ^{[1
]}

Cortes, Jorge E. ^{[2
]}

Kantarjian, Hagop M. ^{[2
]}

Shah, Neil P. ^{[3
]}

Bixby, Dale ^{[4
]}

Flinn, Ian W. ^{[5
]}

O'Hare, Thomas ^{[6
]}

Hu, Simin ^{[8
]}

Rivera, Victor M. ^{[8
]}

Clackson, Tim ^{[8
]}

Turner, Christopher D. ^{[8
]}

Haluska, Frank G. ^{[8
]}

Druker, Brian J. ^{[7
]}

Deininger, Michael W. ^{[6
,7
]}

Talpaz, Moshe ^{[4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[5] Sarah Cannon Res Inst, Nashville, TN USA

[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[8] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷

关键词：

D O I：

10.1016/j.clml.2014.06.069

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

404

引用

页码：S137 / S138

页数：2

共 50 条

[41] Hematologic safety data of single-agent ponatinib from a phase I and phase II trial in Philadelphia chromosome-positive (Ph plus ) CML/ALL patients. [J].

Greer, Devon M. ;

Liewer, Susanna ;

Akhtari, Mojtaba .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[42] Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes [J].

Kebriaei, Partow ;

Saliba, Rima ;

Rondon, Gabriela ;

Chiattone, Alexandre ;

Luthra, Rajyalakshmi ;

Anderlini, Paolo ;

Andersson, Borje ;

Shpall, Elizabeth ;

Popat, Uday ;

Jones, Roy ;

Worth, Laura ;

Ravandi, Farhad ;

Thomas, Deborah ;

O'Brien, Susan ;

Kantarjian, Hagop ;

de Lima, Marcos ;

Giralt, Sergio ;

Champlin, Richard .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (04) :584-592

[43] Efficacy and Safety of Ponatinib in Patients with Accelerated Phase or Blast Phase Chronic Myeloid Leukemia (AP-CML or BP-CML) or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): 12-Month Follow-up of the PACE Trial [J].

Kantarjian, Hagop M. ;

Kim, Dong-Wook ;

Pinilla-Ibarz, Javier ;

le Coutre, Philipp ;

Paquette, Ronald ;

Chuah, Charles ;

Nicolini, Franck E. ;

Apperley, Jane ;

Khoury, H. Jean ;

Talpaz, Moshe ;

DiPersio, John F. ;

DeAngelo, Daniel ;

Abruzzese, Elisabetta ;

Rea, Delphine ;

Baccarani, Michele ;

Muller, Martin C. ;

Gambacorti-Passerini, Carlo ;

Wong, Stephane ;

Lustgarten, Stephanie ;

Rivera, Victor M. ;

Clackson, Tim ;

Turner, Christopher D. ;

Haluska, Frank G. ;

Guilhot, Francois ;

Deininger, Michael W. ;

Hochhaus, Andreas ;

Hughes, Timothy P. ;

Goldman, John ;

Shah, Neil ;

Cortes, Jorge E. .

BLOOD, 2012, 120 (21)

[44] Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph plus ) Leukemia: Results From the PACE Trial [J].

Hochhaus, Andreas ;

Kim, Dong-Wook ;

Pinilla-Ibarz, Javier ;

le Coutre, Philipp ;

Paquette, Ronald ;

Chuah, Charles ;

Nicolini, Franck E. ;

Apperley, Jane ;

Khoury, H. Jean ;

Talpaz, Moshe ;

DiPersio, John F. ;

DeAngelo, Daniel ;

Abruzzese, Elisabetta ;

Rea, Delphine ;

Baccarani, Michele ;

Muller, Martin C. ;

Gambacorti-Passerini, Carlo ;

Wong, Stephane ;

Lustgarten, Stephanie ;

Rivera, Victor M. ;

Clackson, Tim ;

Turner, Christopher D. ;

Haluska, Frank G. ;

Guilhot, Francois ;

Deininger, Michael W. ;

Hughes, Timothy P. ;

Goldman, John M. ;

Shah, Neil ;

Kantarjian, Hagop M. ;

Cortes, Jorge E. .

BLOOD, 2012, 120 (21)

[45] Bosutinib (BOS) for previously treated patients with Philadelphia chromosome-positive (Ph plus ) leukemia: ≥8-year update of a phase 1/2 study [J].

Bruemmendorf, T. H. ;

Cortes, J. E. ;

Schafhausen, P. ;

Kindler, T. ;

Saussele, S. ;

Mueller, M. C. ;

Goh, Y. T. ;

Yilmaz, M. ;

Klisovic, R. B. ;

Purcell, S. ;

Viqueira, A. ;

Leip, E. ;

Gambacorti-Passerini, C. .

ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) :74-74

[46] Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute [J].

Kidoguchi, Keisuke ;

Ureshino, Hiroshi ;

Kizuka-Sano, Haruna ;

Yamaguchi, Kyosuke ;

Katsuya, Hiroo ;

Kubota, Yasushi ;

Ando, Toshihiko ;

Miura, Masatomo ;

Takahashi, Naoto ;

Kimura, Shinya .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (02) :199-204

[47] Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute [J].

Keisuke Kidoguchi ;

Hiroshi Ureshino ;

Haruna Kizuka-Sano ;

Kyosuke Yamaguchi ;

Hiroo Katsuya ;

Yasushi Kubota ;

Toshihiko Ando ;

Masatomo Miura ;

Naoto Takahashi ;

Shinya Kimura .

International Journal of Hematology, 2021, 114 :199-204

[48] Allogeneic bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in first complete remission: Long-term follow-up. [J].

Snyder, DS ;

Nademanee, AP ;

O'Donnell, MR ;

Parker, PM ;

Stein, AS ;

Margolin, K ;

Somlo, G ;

Molina, A ;

Spielberger, R ;

Kashyap, A ;

Fung, H ;

Vora, N ;

Slovak, ML ;

Dagis, A ;

Negrin, RS ;

Amylon, MD ;

Blume, KG ;

Forman, SJ .

BLOOD, 1998, 92 (10) :657A-657A

[49] Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH plus ) Chronic Myeloid Leukemia (CML) or PH plus Acute Lymphoblastic Leukemia (ALL): a Pharmacokinetic Study [J].

Hijiya, Nobuko ;

Zwaan, C. Michel ;

Rizzari, Carmelo ;

Foa, Roberto ;

Abbink, Floor ;

Lancaster, Donna ;

Landman-Parker, Judith ;

Millot, Frederic ;

Moppett, John ;

Nelken, Brigitte ;

Ducassou, Stephane ;

Putti, Maria Caterina ;

Tian, Xianbin ;

Sinclair, Karen ;

Santanastasio, Helene ;

Buchbinder, Aby ;

Kearns, Pamela .

PEDIATRIC BLOOD & CANCER, 2017, 64 :S34-S34

[50] A Phase II Study of the Sequential Combination of Low-Intensity Chemotherapy (mini-hyper-CVD) and Ponatinib Followed By Blinatumomab and Ponatinib in Patients with Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) [J].

Nguyen, Daniel ;

Jabbour, Elias ;

Short, Nicholas ;

Issa, Ghayas C. ;

Yilmaz, Musa ;

Daver, Naval ;

Pemmaraju, Naveen ;

Chien, Kelly S. ;

Masarova, Lucia ;

Ravandi, Farhad ;

Jain, Nitin ;

Deen, Wuliamatu ;

Zhao, Min ;

Loiselle, Christopher ;

Waller, Lourdes ;

Banks, Glenda ;

Garris, Rebecca ;

Kantarjian, Hagop .

BLOOD, 2022, 140 :6127-6129

← 1 2 3 4 5 →